New Protocol: Enasidenib in older patients with late-stage mutant-IDH2 relapsed/refractory AML
|New Protocol: Enasidenib in older patients with late-stage mutant-IDH2 relapsed/refractory AML|
Blood. 2022 Jun 17;blood.2021014901.
de Botton, Stéphane et al. “Enasidenib vs conventional care in mutant-IDH2 relapsed/refractory acute myeloidleukemia: a randomized, phase 3 trial.”
Reviewed by Hasan Çağrı Yıldırım, MD on Jul 06, 2022
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.